Compare ICFI & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ICFI | PRGO |
|---|---|---|
| Founded | 1969 | 1887 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.5B |
| IPO Year | 2006 | 2013 |
| Metric | ICFI | PRGO |
|---|---|---|
| Price | $70.31 | $11.78 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $99.25 | $19.33 |
| AVG Volume (30 Days) | 270.9K | ★ 3.1M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | 0.77% | ★ 10.16% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 4.95 | N/A |
| Revenue | ★ $1,229,162,000.00 | $800,000.00 |
| Revenue This Year | $4.12 | N/A |
| Revenue Next Year | $5.33 | $1.02 |
| P/E Ratio | $14.72 | ★ N/A |
| Revenue Growth | ★ 3.72 | N/A |
| 52 Week Low | $64.34 | $9.23 |
| 52 Week High | $101.71 | $28.44 |
| Indicator | ICFI | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 50.05 | 61.27 |
| Support Level | $64.34 | $9.24 |
| Resistance Level | $83.85 | $15.08 |
| Average True Range (ATR) | 2.28 | 0.51 |
| MACD | 1.04 | 0.26 |
| Stochastic Oscillator | 58.47 | 95.35 |
ICF International Inc provides professional services and technology-based solutions to government and commercial clients, including management, marketing, technology, and policy consulting and implementation services. Its services support clients that operate in four key markets that include Energy, Environment, Infrastructure and Disaster Recovery; Health and Social Programs and Security and Other Civilian & Commercial. The Company's majority clients are United States federal government departments and agencies. It operates in a single segment, which is providing professional services.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.